In this 2-part series, 2 renowned healthcare economists give their opinions of what US healthcare would look like should Mitt Romney be elected President in November.

Dr. Ed Septimus reveals why the surgical-site infection rate remains high and what steps can be taken to reduce it.

Because the healthcare budget is not likely to get any bigger, Dr. John Marshall comments that we may need to 'clean the healthcare closet' to make room for new therapies. What can we do without?

Dr. John Marshall says that his efficiency as a clinician is undermined as he spends more and more time entering data into the EMR with less and less administrative support. Is there a way out?

Drug shortages occur in all disease states and affect all populations. Dr. Maris discusses this serious and growing issue.

It has been 40 years since President Nixon signed the National Cancer Act. What have learned? What progress have we made? And what challenges lie ahead?

CMS Administrator Donald M. Berwick, MD, MPP, and Richard J. Gilfillan, MD, Acting Director, Center for Medicare and Medicaid Innovation, discuss the final ACO rules and how they will affect doctors.

Bioethicist Arthur Caplan, PhD, offers $10,000 if GOP presidential hopeful Michele Bachmann proves that taking the HPV vaccine for cervical cancer has led to "retardation," as she recently claimed.

An ethics expert says that patients who refuse to adhere to recommended care differ from those who want to but fall short of their good intentions. The way you deal with each could affect the results.

Some drugs that are currently on the market have never been approved by the US Food and Drug Administration (FDA).